Literature DB >> 7726604

Gene therapy for cancers.

L Lashford1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7726604      PMCID: PMC1030081          DOI: 10.1136/adc.71.6.485

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  23 in total

1.  Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection.

Authors:  D G Miller; M A Adam; A D Miller
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

2.  Homologous recombination of SV40 DNA in COS7 cells occurs with high frequency in a gene dose independent fashion.

Authors:  W Rommerskirch; I Graeber; M Grässmann; A Grässmann
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.

Authors:  J C Reed; C Stein; C Subasinghe; S Haldar; C M Croce; S Yum; J Cohen
Journal:  Cancer Res       Date:  1990-10-15       Impact factor: 12.701

4.  Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells.

Authors:  A Porgador; E Tzehoval; A Katz; E Vadai; M Revel; M Feldman; L Eisenbach
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

5.  Targeting of an inducible toxic phenotype in animal cells.

Authors:  E Borrelli; R Heyman; M Hsi; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

6.  Production of chimaeric mice containing embryonic stem (ES) cells carrying a homoeobox Hox 1.1 allele mutated by homologous recombination.

Authors:  A Zimmer; P Gruss
Journal:  Nature       Date:  1989-03-09       Impact factor: 49.962

7.  Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

Authors:  S A Rosenberg; B S Packard; P M Aebersold; D Solomon; S L Topalian; S T Toy; P Simon; M T Lotze; J C Yang; C A Seipp
Journal:  N Engl J Med       Date:  1988-12-22       Impact factor: 91.245

8.  Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy.

Authors:  B E Huber; C A Richards; T A Krenitsky
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

9.  A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

Authors:  S A Rosenberg; M T Lotze; L M Muul; A E Chang; F P Avis; S Leitman; W M Linehan; C N Robertson; R E Lee; J T Rubin
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245

10.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells.

Authors:  H J Huang; J K Yee; J Y Shew; P L Chen; R Bookstein; T Friedmann; E Y Lee; W H Lee
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.